Introduction {#Sec1}
============

*Haemophilus influenzae* type b (Hib) is responsible for most cases of invasive *H. influenzae* disease, including meningitis and septicemia, in unvaccinated children. With the decline in the incidence of invasive Hib disease as a result of the Hib vaccine program, nontypeable *H. influenzae* (NTHi) has become an important cause of invasive *H. influenzae* disease in vaccinated children \[[@CR1]\].

NTHi is part of the normal flora in the upper respiratory tract of children and commonly causes local respiratory tract diseases, including otitis media, sinusitis, conjunctivitis, and bronchitis \[[@CR2], [@CR3]\]. Meningitis and septicemia have been reported rarely in children with underlying predisposing conditions, including head trauma \[[@CR4]\], cerebrospinal fluid (CSF) leakage \[[@CR5]\], and immune compromise \[[@CR6]\], in neonates associated with colonization of the maternal genital tract \[[@CR7], [@CR8]\], and more rarely in previously healthy children \[[@CR9]--[@CR11]\].

According to a Japanese nationwide surveillance system, the incidence of *H. influenzae* meningitis was 4.7 cases/100.000/year in 1994 \[[@CR12]\]. The frequency with which NTHi meningitis in children occurs seems to vary, depending on the populations surveyed: 4 (0.7%) of the 535 patients with *H. influenzae* meningitis were NTHi strains \[[@CR13]\]; 2 (4.9%) of the 41 pediatric patients with *H. influenzae* meningitis were NTHi strains \[[@CR14]\].

We report a case of a previously healthy 2-year-old girl who developed meningitis and septicemia caused by NTHi biotype ΙΙΙ, and wish to emphasize that NTHi must be borne in mind as a potential pathogen that can cause invasive disease, even in previously healthy children.

Case report {#Sec2}
===========

On 7 September 2008 a previously healthy 2-year-old girl was admitted to the hospital with a 12-h history of fever and vomiting. She had no rhinorrhea or cough before her hospital stay. She had been born at 40 weeks of gestation, and her birth weight was 3062 g. Subsequent mental and physical development had been normal. She had no history of head trauma, CSF leakage, or immune compromise. She had been immunized with various vaccines as appropriate according to the immunization schedule for children (BCG, diphtheria, tetanus, pertussis, poliomyelitis, measles, rubella, and varicella). She lived with her parents and 3-year-old brother, and attended a nursery school.

On admission, she had a body temperature of 39.2°C, heart rate of 122 beats/min, respiratory rate of 40/min, and an instant capillary refill time without cold peripheries. Consciousness was clear. Ear--nose--throat examination showed a red and swollen pharynx. No clinical findings of otitis media were observed. Examination of her chest and abdomen was unremarkable. No rashes, anterior fontanelle bulging or nuchal rigidity was observed. Laboratory data on admission were: white blood cell (WBC) count, 13400/μl (neutrophils 91%, monocytes 2%, lymphocytes 7%); serum aspartate aminotransferase (ALT), 29 IU/l; serum alanine aminotransferase (AST), 17 IU/l; serum lactate dehydrogenase (LDH), 252 IU/l; serum C-reactive protein (CRP), 1.5 mg/dl. An abdominal X-ray showed no abnormalities. She was initially treated with intravenous fluid and antipyretics, with her condition monitored closely.

On the second day of admission, the vomiting persisted, and the patient complained of headache. She had a body temperature of 39.3°C, heart rate of 145 beats/min, and respiratory rate of 45/min. She became disoriented and the Glasgow coma scale showed an eye opening (E) score of 4, verbal response (V) score of 2, and best motor response (M) score of 5. Nuchal rigidity and Brudzinski's sign were positive. No anterior fontanelle bulging or hemiparesis were observed, and Kernig's sign and Babinski's sign were negative. The laboratory data on September 8 were: WBC count, 15300/μl (neutrophils 82%, monocytes 9%, lymphocytes 8%); ALT, 30 IU/l; AST, 16 IU/l; LDH, 307 IU/l; fasting blood glucose, 144 mg/dl; CRP, 15.0 mg/dl; CSF cell count, 3146 cells/μl (polymorphonuclear leucocytes, 78%); CSF protein, 51 mg/dl; CSF glucose, 35 mg/dl. Gram staining of the CSF revealed the presence of small, Gram-negative, pleomorphic rods resembling *H. influenzae.* However, a CSF test kit designed to detect the capsular antigens of bacteria causing meningitis (Pastrorex Meningitis; Bio-Rad Laboratories, Tokyo, Japan) gave a negative result for Hib antigen. On the basis of the clinical and laboratory findings, diagnosis of bacterial meningitis was made, and empiric treatment with ceftriaxone sodium hydrate (CTRX) (120 mg/kg/day, 12-hourly) and meropenem hydrate (MEPM) (140 mg/kg/day, 8-hourly) was started. To avoid neurological sequelae, dexamethasone (0.60 mg/kg/day, 6-hourly) was also administered for 2 days. The CSF culture was positive after incubation at 37°C for 2 days. Blood culture was positive after incubation at 35°C for 3 days. The isolates were subsequently identified as *H. influenzae* by 16S rRNA gene sequencing, followed by a basic local alignment search tool (BLAST) search in the laboratory of Ubukata Kimiko at the Kitasato Institute for Life Sciences Kitasato University. On serotyping \[[@CR15]\], no agglutination was observed with antisera against the capsular serotypes a through f, leading to categorization of the strain as nontypeable. On biotyping \[[@CR16]\], the organism failed to produce indole and to decarboxylate ornithine, but was able to hydrolyze urea, leading to its categorization as biotype ΙΙΙ. *H. influenzae* biotype ΙΙΙ could be distinguished from *H. aegyptius* by its fermentation of xylose or by its growth on tryptic soy agar containing X and V factors \[[@CR17]\]. All of the CSF, blood, and throat swab cultures yielded beta-lactamase-negative NTHi biotype ΙΙΙ. The minimum inhibitory concentrations (MIC) of several antibiotics for the organism are listed in Table [1](#Tab1){ref-type="table"}.Table 1Minimum inhibitory concentration of several antibiotics for nontypeable *Haemophilus influenzae* biotype ΙΙΙ isolated from the cerebrospinal fluidAntibioticMIC (μg/ml)Ampicillin0.25Cefditoren\<0.03Cefcapene\<0.03Cefotaxime\<0.03Panipenem1Telithromycin8Clarithromycin\<0.03Meropenem\<0.03Ceftriaxone\<0.03Chloramphenicol1Levofloxacin\<0.5

A repeat CSF culture on September 9 was also positive. Blood culture was not repeated. On September 12, the fever resolved and the signs of meningeal irritation were no longer positive. We discontinued MEPM on the basis of the result from antibiotic susceptibility testing. Repeat CSF cultures on September 12 and 18 were both negative. On September 24, CTRX was stopped when the serum CRP had remained within the normal range for 7 days. On September 28, she was discharged without any apparent neurological sequelae (Fig. [1](#Fig1){ref-type="fig"}). Because of the unusual finding of NTHi meningitis, further investigations were performed on the child. The results revealed normal levels of immunoglobulin G (IgG), IgG subtypes, IgA, IgM, CD4, CD8, and of the blood complement components. Cranial and paranasal sinus computed tomography and magnetic resonance imaging of the head were normal. HIV testing was not performed.Fig. 1Clinical course of a 2-year-old girl with nontypeable *Haemophilus influenzae* meningitis. *DEXA* dexamethasone, *CTRX* ceftriaxone, *MEPM* meropenem, *WBC* white blood cell, *CRP* C-reactive protein

Discussion {#Sec3}
==========

We report a rare case of meningitis and septicemia caused by NTHi biotype ΙΙΙ. This case demonstrates that NTHi should be borne in mind as a potential pathogen that can cause meningitis and septicemia, even in previously healthy children. Almost all cases of *H. influenzae* meningitis in unvaccinated children are caused by Hib or biotype Ι strains \[[@CR16]\]. In contrast with Hib, NTHi is primarily recognized as a commensal organism in the upper respiratory tract \[[@CR3]\]. However, NTHi biotype ΙΙΙ seems to have the potential to cause invasive disease such as meningitis \[[@CR4], [@CR9], [@CR10]\] and septicemia \[[@CR7], [@CR9]\]. Therefore, children presenting with invasive NTHi disease should be promptly subjected to further evaluation and diagnostic imaging for identifying predisposing factors such as head trauma \[[@CR4]\], CSF leakage \[[@CR5]\], and immune compromise \[[@CR6]\].

Concerning the possible route of transmission of NTHi biotype ΙΙΙ, it seems likely that the meningitis and septicemia in our patient were caused by the strain isolated from her throat culture, because all strains isolated from the CSF, blood, and throat belonged to identical biotypes and the MIC distributions were almost identical.

A subgroup of NTHi strains is spontaneous capsule-deficient progeny of Hib strains called b^−^ strains. The b^−^ strains might be generated by loss of their capsulation ability through homologous recombination. The frequency of b^−^ strains in Hib is 0.1--0.3% \[[@CR14], [@CR18], [@CR19]\]. The b^−^ strains cannot be ruled out for our patient's strain, because the slide agglutination test against the capsular serotypes are not able to differentiate between NTHi and b^−^ strains.

Since the 1980s, when Hib conjugate vaccines were introduced in many foreign countries, the incidence of Hib meningitis has decreased dramatically. As a consequence, NTHi has become relatively more important as a pathogen for meningitis. In December 2008, Hib conjugate vaccine was introduced in Japan. Since the introduction of Hib conjugate vaccine, investigation of capsular serotypes is necessary in all cases of *H. influenzae* meningitis, because Hib vaccine does not protect against meningitis due to nontypeable strains. We conclude that NTHi biotype ΙΙΙ must be borne in mind as a potential pathogen that can cause meningitis and septicemia, even in previously healthy children.
